These injections are formulated with compounds such as Vitamin B12, choline, methionine, and inositol, which are aimed at enhancing fat metabolism, improving liver function, and boosting energy levels
Additionally, the injections are typically well-tolerated, with few side effects reported
Secondary outcome measures included change from baseline MHFMS score following 12 versus 6 months treatment, estimates of innervation via maximum ulnar compound muscle action potential (CMAP), dual-energy X-ray absorptiometry (DEXA), evaluation of body composition and bone density, quantitative assessment of SMN mRNA
Contamination Testing Each lot undergoes testing for: Bacterial Endotoxin, Heavy metals, Bicrobial contamination and residual solvents (where applicable)
Tivanisiran, a novel siRNA for the treatment of dry eye disease